Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ya‐Ru Miao"'
Autor:
Chen Dong, Ya‐ru Miao, Rui Zhao, Mei Yang, An‐yuan Guo, Zhong‐hui Xue, Teng Li, Qiong Zhang, Yanfeng Bao, Chen Shen, Chi Sun, Ying Yang, Xi‐xi Gu, Yi Jin, Rong Li, Min Xu, Jia‐xin Guo, Zhi‐ying Zong, Wei Zhou, Mei He, Dan‐ni Wang, Jian‐you Su, Xiao‐ming Zhang, Xu‐hui Zeng, Jian‐lin Gao, Zhi‐feng Gu
Publikováno v:
Advanced Science, Vol 9, Iss 36, Pp n/a-n/a (2022)
Abstract Centenarians, who show mild infections and low incidence of tumors, are the optimal model to investigate healthy aging. However, longevity related immune characteristics has not been fully revealed largely due to lack of appropriate controls
Externí odkaz:
https://doaj.org/article/92a306777f614196a2cc3df9cb5d91a4
hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets
Publikováno v:
Genomics, Proteomics & Bioinformatics, Vol 18, Iss 2, Pp 120-128 (2020)
Transcription factors (TFs) as key regulators play crucial roles in biological processes. The identification of TF–target regulatory relationships is a key step for revealing functions of TFs and their regulations on gene expression. The accumulate
Externí odkaz:
https://doaj.org/article/a12aa05604ce41759bbcbcfdb9dd1ef1
Autor:
Sheng-Yan Lin, Fei-Fei Hu, Ya-Ru Miao, Hui Hu, Qian Lei, Qiong Zhang, Qiubai Li, Hongxiang Wang, Zhichao Chen, An-Yuan Guo
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 18, Iss , Pp 476-484 (2019)
Cytogenetically normal acute myeloid leukemia (CN-AML) presents with diverse outcomes in different patients and is categorized as an intermediate prognosis group. It is important to identify prognostic factors for CN-AML risk stratification. In this
Externí odkaz:
https://doaj.org/article/e2f19097803d4c2ba0f5ab60cad23fe5
Autor:
Ya-Ru Miao, Wen Liu, Zhaodong Zhong, Yong You, Yutong Tang, Weiming Li, Xiaojian Zhu, An-Yuan Guo
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Most relapsed chronic myeloid leukemia (CML) patients after tyrosine kinase inhibitor (TKI) discontinuation are in a chronic phase and could achieve remission through restarting the TKI treatment. Here we reported a case of sudden lymphoid blast cris
Externí odkaz:
https://doaj.org/article/d371cab397284b2f8d0f1f99143b6f53
Publikováno v:
Cells, Vol 11, Iss 18, p 2802 (2022)
Although immune checkpoint blockade (ICB) therapies have achieved great progress, the patient response varies among cancers. In this study, we analyzed the potential genomic indicators contributing to ICB therapy response. The results showed that hig
Externí odkaz:
https://doaj.org/article/71dabbf614984f779c4ae9feff9a8ef5
Autor:
Hui Hu, Wei Huang, Hong Zhang, Jianye Li, Qiong Zhang, Ya-Ru Miao, Fei-Fei Hu, Lu Gan, Zhenhong Su, Xiangliang Yang, An-Yuan Guo
Publikováno v:
Cells, Vol 11, Iss 13, p 2116 (2022)
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, but its regulatory mechanism remains unclear and potential clinical biomarkers are still lacking. Co-regulation of TFs and miRNAs in HCC and FFL module studi
Externí odkaz:
https://doaj.org/article/387a0dd4325a44b599b803ba4c7eff43
Publikováno v:
Advanced Science, Vol 7, Iss 7, Pp n/a-n/a (2020)
Abstract The distribution and abundance of immune cells, particularly T‐cell subsets, play pivotal roles in cancer immunology and therapy. T cells have many subsets with specific function and current methods are limited in estimating them, thus, a
Externí odkaz:
https://doaj.org/article/407372ffcceb439cb75c58e8f63570e1
Autor:
Yanbo Yang, Dongyang Wang, Ya-Ru Miao, Xiaohong Wu, Haohui Luo, Wen Cao, Wenqian Yang, Jianye Yang, An-Yuan Guo, Jing Gong
Publikováno v:
Nucleic Acids Research. 51:D192-D198
Long non-coding RNAs (lncRNAs) act as versatile regulators of many biological processes and play vital roles in various diseases. lncRNASNP is dedicated to providing a comprehensive repository of single nucleotide polymorphisms (SNPs) and somatic mut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e529bae606c49928efedf9a49a9cc3
https://doi.org/10.1093/nar/gkac981
https://doi.org/10.1093/nar/gkac981
Publikováno v:
Cancer Immunology Research. 10:1398-1406
Immune checkpoint blockade (ICB) therapy provides remarkable clinical benefits for multiple cancer types. Much work is currently being conducted to investigate the mechanisms of ICB therapy at the transcriptional level. Integrating the data produced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462ead6d5a2af87b829a201a6c2ca8e8
https://doi.org/10.1158/2326-6066.cir-22-0249
https://doi.org/10.1158/2326-6066.cir-22-0249
Supplementary Table from ICBatlas: A Comprehensive Resource for Depicting Immune Checkpoint Blockade Therapy Characteristics from Transcriptome Profiles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a84c8dd7cd22228991afe0a506709bd
https://doi.org/10.1158/2326-6066.22545042
https://doi.org/10.1158/2326-6066.22545042
